Download FREE Report Sample
Download Free sampleCeftazidime injection is a western medicine preparation, mainly used for respiratory tract infections and urinary tract infections caused by sensitive bacteria.Since the global outbreak of COVID-19, these drugs have also entered a stage of shortage .
Ceftazidime Injection Market contains market size and forecasts of Ceftazidime Injection in global, including the following market information:
Global Ceftazidime Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ceftazidime Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Ceftazidime Injection companies in 2021 (%)
The global Ceftazidime Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1g/vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ceftazidime Injection include Teligent, Pfizer, B Braun, Sagent, WG Critical Care, GSK, Allergan, CSPC Zhongnuo Pharmaceutical and Anhui Welman, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ceftazidime Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ceftazidime Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ceftazidime Injection Market Segment Percentages, by Type, 2021 (%)
1g/vial
2g/vial
6g/vial
Global Ceftazidime Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ceftazidime Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Recovery Center
Global Ceftazidime Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ceftazidime Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ceftazidime Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ceftazidime Injection revenues share in global market, 2021 (%)
Key companies Ceftazidime Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Ceftazidime Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teligent
Pfizer
B Braun
Sagent
WG Critical Care
GSK
Allergan
CSPC Zhongnuo Pharmaceutical
Anhui Welman
Guangzhou Baiyunshan Tianxin Pharmaceutical
Hainan Hailing Chemipharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
